A Phase II Study of First-Line Sintilimab Combined With Anlotinib and Platinum-Based Chemotherapy in Unresectable MPM

This single-arm, open-label, phase II trial enrolls treatment-naïve patients aged ≥18 years with histologically confirmed unresectable or advanced MPM (stage IIIB/IV), ECOG 0-1, and measurable lesions per mRECIST 1.1.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-29
DOI
https://doi.org/10.5281/zenodo.16793063
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase II Study of First-Line Sintilimab Combined With Anlotinib and Platinum-Based Chemotherapy in Unresectable MPM

Zenodo (CERN European Organization for Nuclear Research)
Lung Cancer Research Studies
article

A Phase II Study of First-Line Sintilimab Combined With Anlotinib and Platinum-Based Chemotherapy in Unresectable MPM

article en

Abstract

This single-arm, open-label, phase II trial enrolls treatment-naïve patients aged ≥18 years with histologically confirmed unresectable or advanced MPM (stage IIIB/IV), ECOG 0-1, and measurable lesions per mRECIST 1.1.

Zenodo (CERN European Organization for Nuclear Research)
Cancer Hospital of Chinese Academy of Medical Sciences (CN)
Openalex Percentile: Top 38%
Lung Cancer Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Phase II Study of First-Line Sintilimab Combined With Anlotinib and Platinum-Based Chemotherapy in Unresectable MPM · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS